Alx Oncology Holdings
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | -4.4% | +3,984.4% | -12.8% | -19.4% | -20.9% | -39.1% | -60.0% | |
| – | -3.9% | +4,344.8% | -15.8% | -26.2% | -30.4% | -28.8% | -62.2% | |
| – | +9.1% | +4,715.6% | -16.2% | -86.6% | -54.1% | -21.6% | -6.8% | |
| – | +9.1% | +4,715.6% | -16.2% | -26.8% | -31.4% | -30.1% | -64.9% | |
| – | -42.5% | – | – | – | +0.0% | -10.8% | -66.6% | |
| – | – | – | – | – | – | – | – | |
| – | -10.0% | -94.0% | +1,625.0% | +333.6% | – | – | – | |
| – | +445.1% | -43.3% | +176.0% | +151.1% | +22.8% | -35.4% | -3.2% | |
| – | +166.1% | +24.5% | +146.5% | +85.2% | +27.1% | -48.6% | +32.7% | |
| – | – | – | – | +40.3% | +51.3% | +49.0% | +122.3% | |
| – | +437.7% | -99.9% | +94,000.0% | +114.5% | +6.4% | -47.7% | +9.3% | |
| – | – | – | – | – | +2.7% | -1.8% | -52.1% | |
| – | -103.0% | – | -15.5% | -27.4% | -28.0% | -40.1% | -77.1% | |
| – | – | – | – | – | – | – | – | |
| – | +0.0% | +81.5% | +1.2% | +1.0% | +5.6% | +21.4% | +2.8% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.